Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2022 Mar 12;14(3):e23094.
doi: 10.7759/cureus.23094. eCollection 2022 Mar.

Immunodeficiency: A Protective Factor for COVID-19?

Zain AlShanableh  1 , Mohammad Haidous  1 , Krista M Wong  1 , Mohamad Al-Saed  1 , Basel Altaqi  1
Affiliations
Case Reports

Immunodeficiency: A Protective Factor for COVID-19?

Zain AlShanableh et al. Cureus. .

Abstract

Coronavirus disease 2019 (COVID-19) is an infection that involves the respiratory tract and is attributed to severe acute respiratory syndrome coronavirus 2. While most people develop mild or uncomplicated illness, approximately 15% develop a severe disease that requires oxygen support, and 5% develop a critical disease. While immunodeficiency is reported as a risk factor for COVID-19, we present a patient with idiopathic CD4+ lymphocytopenia who developed severe COVID-19 with an unexpected clinical course and complete recovery.

Keywords: ards; cd4+ lymphocytopenia; covid-19; cytokine storm; immunodeficiency.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. Computed tomography scan images of the chest.
Diffuse nodular infiltrates (blue arrows).
See this image and copyright information in PMC

References

    1. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Yang X, Yu Y, Xu J, et al. Lancet Respir Med. 2020;8:475–481. - PMC - PubMed
    1. World Health Organization. Living guidance for clinical management of COVID-19. [ Dec; 2021 ];World Health Organization. (2021. https://www.who.int/publications/i/item/WHO-2019-nCoV-clinical-2021-2 2021
    1. The effects of cytokines on T cell differentiation. [ Dec; 2021 ];Flies Flies, A. (2017. https://www.cellsciences.com/resources/whitepaper-the-effects-of-cytokin... 2017
    1. The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): the Perspectives of clinical immunologists from China. [ Jan; 2022 ];Zhang W, Zhao Y, Zhang F, et al. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7102614/ Clin Immunol. 2020 214:108393. - PMC - PubMed
    1. Surviving sepsis campaign: guidelines on the management of critically ill adults with coronavirus disease 2019 (COVID-19) Alhazzani W, Møller MH, Arabi YM, et al. https://doi.org/10.1097/ccm.0000000000004363 Crit Care Med. 2020;48:0–69. - PMC - PubMed

Publication types

LinkOut - more resources